Literature DB >> 7252853

Effects of phenylbutazone on extravascular diffusion, protein binding and urinary excretion of cefazolin in rabbits.

C Carbon, A Contrepois, Y Nivoche, M Grandjean, S Decourt, N P Chau.   

Abstract

The effects of an anti-inflammatory drug, phenylbutazone, on the disposition of a commonly used cephalosporin, cefazolin, were studied in rabbits. The following investigations were made: mathematical analysis of blood levels obtained after i.v bolous injection of cefazolin, alone or combined with phenylbutazone (10 mg/kg), injection 4 hr before; protein binding by ultracentrifugation in vitro; and renal excretion and distribution in extravascular fluid obtained from s.c. tissue cages in vivo. Single i.m. injections of cefazolin (30 mg/kg) were administered either alone or in combination with phenylbutazone (10 or 100 mg/kg i.m.) or 2 or 4 hr before. The mathematical analysis disclosed a competition of phenylbutazone on protein binding of cefazolin. In vitro, phenylbutazone reduced the extent of protein binding of the antibiotic (74-80 to 47-59%). Cefazolin appeared at higher concentrations in extravascular fluid in the presence of phenylbutazone than when administered alone. Phenylbutazone appeared to be responsible for a dose-dependent effect on renal excretion of cefazolin i.e., a reduction of secretion at low doses (10 mg/kg) and a possible reduction of tubular reabsorption at high doses (100 mg/kg). A bidirectional transport of cefazolin in rabbit tubules was thus shown. The interaction of phenylbutazone on the on the disposition of cefazolin appeared also dependent on the time of injection of the former and on the mode of administration of the antibiotic.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7252853

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Reduction in biliary excretion of ceftriaxone by diclofenac in rabbits.

Authors:  M Merle-Melet; N Seta; R Farinotti; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis.

Authors:  V Joly; B Pangon; J M Vallois; L Abel; N Brion; A Bure; N P Chau; A Contrepois; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

3.  Effects of urinary pH on renal interactions between probenecid and cefsulodin in rabbits.

Authors:  F Dromer; A Contrepois; N Brion; C Klein; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

4.  Effects of furosemide, piretanide, and water loading on urinary excretion of cefazolin in humans.

Authors:  C Morgant; A Contrepois; N P Chau; A Romaru; J B Fourtillan; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

5.  Alteration of gentamicin and cefazolin kinetics with control of the hypothyroid state in humans.

Authors:  P Chanson; V Joly; A Contrepois; J J Garaud; J Bauchet; J Mohler; P C Nguyen; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

6.  Effects of diclofenac on ceftriaxone pharmacokinetics in humans.

Authors:  M Merle-Melet; L Bresler; F Lokiec; C Dopff; P Boissel; J B Dureux
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

7.  Renal disposition of ceftazidime illustrated by interferences by probenecid, furosemide, and indomethacin in rabbits.

Authors:  C Carbon; F Dromer; N Brion; A C Cremieux; A Contrepois
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.